Precursor Cell Lymphoblastic Leukemia-lymphoma
📧 Sign up to get email alerts when something new happens for Precursor Cell Lymphoblastic Leukemia-lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-06EMA Authorised: Sprycel (dasatinib) — Bristol-Myers Squibb Pharma EEIG
The EMA authorised Sprycel (dasatinib). It covers chronic myeloid leukemia (BCR-ABL positive) and precursor cell lymphoblastic leukemia-lymp…
-
EMA approval · 2026-03-05EMA Authorised: Imatinib Teva (imatinib) — Teva B.V.
EMA authorised Imatinib Teva (imatinib) for multiple indications including chronic myeloid leukemia, precursor cell lymphoblastic leukemia-l…
-
EMA approval · 2026-02-19EMA Authorised: Enrylaze (crisantaspase) — Jazz Pharmaceuticals Ireland Limited
Enrylaze (crisantaspase) has been authorised by the EMA for precursor cell lymphoblastic leukemia-lymphoma.
-
EMA approval · 2025-11-12EMA Authorised: Glivec (imatinib) — Novartis Europharm Limited
The European Medicines Agency authorised Glivec (imatinib) for multiple indications, including precursor cell lymphoblastic leukemia-lymphom…
-
EMA approval · 2025-06-18EMA Authorised: Phelinun (melphalan hydrochloride) — ADIENNE S.r.l. S.U.
The EMA authorised Phelinun (melphalan hydrochloride) for multiple cancers including multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-05-06EMA Authorised: Imatinib Accord (imatinib) — Accord Healthcare S.L.U.
The EMA authorised Imatinib Accord (imatinib) for several indications, including Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dermatofibr…
-
EMA approval · 2024-10-25EMA Authorised: Oncaspar (pegaspargase) — Les Laboratoires Servier
The European Medicines Agency authorised Oncaspar (pegaspargase) from Les Laboratoires Servier for precursor cell lymphoblastic leukemia-lym…
-
EMA approval · 2024-07-22EMA Authorised: Evoltra (clofarabine) — Sanofi B.V.
The European Medicines Agency authorised Evoltra (clofarabine) for the treatment of precursor cell lymphoblastic leukemia-lymphoma, with San…
-
EMA approval · 2023-11-20EMA Authorised: Spectrila (asparaginase) — Medac Gesellschaft fuer klinische Spezialpraeparate mbH
The EMA authorised Spectrila (asparaginase) for precursor cell lymphoblastic leukemia-lymphoma (ALL/LBL) in collaboration with Medac as the …